|
1
|
Liu X, Li Z, Song Y, Wang R, Han L, Wang
Q, Jiang K, Kang C and Zhang Q: AURKA induces EMT by regulating
histone modification through Wnt/β-catenin and PI3K/Akt signaling
pathway in gastric cancer. Oncotarget. 7:33152–33164.
2016.PubMed/NCBI
|
|
2
|
Yoon H and Kim N: Diagnosis and management
of high risk group for gastric cancer. Gut Liver. 9:5–17. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takatsu Y, Hiki N, Nunobe S, Ohashi M,
Honda M, Yamaguchi T, Nakajima T and Sano T: Clinicopathological
features of gastric cancer in young patients. Gastric Cancer.
19:472–478. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shimada H, Noie T, Ohashi M, Oba K and
Takahashi Y: Clinical significance of serum tumor markers for
gastric cancer: A systematic review of literature by the Task Force
of the Japanese Gastric Cancer Association. Gastric Cancer.
17:26–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang C, Zhang J, Cai M, Zhu Z, Gu W, Yu Y
and Zhang X: DBGC: A database of human gastric cancer. PLoS One.
10:e01425912015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim T, Chung H, Yu W, Kim JY, Kim GC and
Choi J: Localization of gastric cancer by CT gastrography: A
prospective study. Hepatogastroenterology. 56:1580–1584.
2009.PubMed/NCBI
|
|
7
|
Yanai H, Matsubara Y, Kawano T, Okamoto T,
Hirano A, Nakamura Y, Nakamura H, Nishikawa J and Okita K: Clinical
impact of strip biopsy for early gastric cancer. Gastrointest
Endosc. 60:771–777. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kanda M and Kodera Y: Recent advances in
the molecular diagnostics of gastric cancer. World J Gastroenterol.
21:9838–9852. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang YK, Yu JC, Kang WM, Ma ZQ, Ye X,
Tian SB and Yan C: Significance of serum pepsinogens as a biomarker
for gastric cancer and atrophic gastritis screening: A Systematic
Review and Meta-Analysis. PLoS One. 10:e01420802015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shin VY, Ng EK, Chan VW, Kwong A and Chu
KM: A three-miRNA signature as promising non-invasive diagnostic
marker for gastric cancer. Mol Cancer. 14:2022015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song D, Yue L, Zhang J, Ma S, Zhao W, Guo
F, Fan Y, Yang H, Liu Q, Zhang D, et al: Diagnostic and prognostic
significance of serum apolipoprotein C-I in triple-negative breast
cancer based on mass spectrometry. Cancer Biol Ther. 17:635–647.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang X, Han J, Hardie DB, Yang J and
Borchers CH: The use of matrix coating assisted by an electric
field (MCAEF) to enhance mass spectrometric imaging of human
prostate cancer biomarkers. J Mass Spectrom. 51:86–95. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shi J, Yang H, Duan X, Li L, Sun L, Li Q
and Zhang J: Apolipoproteins as differentiating and predictive
markers for assessing clinical outcomes in patients with small cell
lung cancer. Yonsei Med J. 57:549–556. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cohen M, Yossef R, Erez T, Kugel A, Welt
M, Karpasas MM, Bones J, Rudd PM, Taieb J, Boissin H, et al: Serum
apolipoproteins C-I and C-III are reduced in stomach cancer
patients: Results from MALDI-based peptidome and immuno-based
clinical assays. PLoS One. 6:e145402011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vieira M and Saraiva MJ: Transthyretin: A
multifaceted protein. Biomol Concepts. 5:45–54. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fentz AK, Spörl M, Spangenberg J, List HJ,
Zornig C, Dörner A, Layer P, Juhl H and David KA: Detection of
colorectal adenoma and cancer based on transthyretin and C3a-desArg
serum levels. Proteomics Clin Appl. 1:536–544. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Helgason HH, Engwegen JY, Zapatka M,
Vincent A, Cats A, Boot H, Beijnen JH and Schellens JH:
Identification of serum proteins as prognostic and predictive
markers of colorectal cancer using surface enhanced laser
desorption ionization-time of flight mass spectrometry. Oncol Rep.
24:57–64. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Choi BW, Kim HW, Won KS, Song BI, Cho KB
and Bae SU: Diagnostic accuracy of 18F-FDG PET/CT for detecting
synchronous advanced colorectal neoplasia in patients with gastric
cancer. Medicine (Baltimore). 95:e47412016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Smyth EC, Verheij M, Allum W, Cunningham
D, Cervantes A and Arnold D; ESMO Guidelines Committee, : Gastric
cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment
and follow-up. Ann Oncol. 27 Suppl 5:v38–v49. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rahman R, Asombang AW and Ibdah JA:
Characteristics of gastric cancer in Asia. World J Gastroenterol.
20:4483–4490. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kang JI, Chung HC, Jeung HC, Kim SJ, An SK
and Namkoong K: FKBP5 polymorphisms as vulnerability to anxiety and
depression in patients with advanced gastric cancer: A controlled
and prospective study. Psychoneuroendocrinology. 37:1569–1576.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Choi J, Kim SG, Im JP, Kim JS and Jung HC:
Long-term clinical outcomes of endoscopic resection for early
gastric cancer. Surg Endosc. 29:1223–1230. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Duffy MJ, Lamerz R, Haglund C, Nicolini A,
Kalousová M, Holubec L and Sturgeon C: Tumor markers in colorectal
cancer, gastric cancer and gastrointestinal stromal cancers:
European group on tumor markers 2014 guidelines update. Int J
Cancer. 134:2513–2522. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jin Z, Jiang W and Wang L: Biomarkers for
gastric cancer: Progression in early diagnosis and prognosis
(Review). Oncol Lett. 9:1502–1508. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dellière S and Cynober L: Is transthyretin
a good marker of nutritional status? Clin Nutr. 36:364–370. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shimura T, Shibata M, Gonda K, Okayama H,
Saito M, Momma T, Ohki S and Kono K: Serum transthyretin level is
associated with prognosis of patients with gastric cancer. J Surg
Res. 227:145–150. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Su WP, Sun LN, Yang SL, Zhao H, Zeng TY,
Wu WZ and Wang D: Apolipoprotein C1 promotes prostate cancer cell
proliferation in vitro. J Biochem Mol Toxicol. 32:e221582018.
View Article : Google Scholar
|
|
28
|
Shachter NS: Apolipoproteins C-I and C-III
as important modulators of lipoprotein metabolism. Curr Opin
Lipidol. 12:297–304. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ghahremanfard F, Mirmohammadkhani M,
Shahnazari B, Gholami G and Mehdizadeh J: The valuable role of
measuring serum lipid profile in cancer progression. Oman Med J.
30:353–357. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang T, Cui G, Feng WM, Shi QL, Cui J, Li
XN, Wang QC and Shen H: Correlation analysis between glycolipids
metabolism and clinicopathologic fe atures in patients with gastric
cancer. Zhonghua Yi Xue Za Zhi. 96:2545–2547. 2016.(In Chinese).
PubMed/NCBI
|
|
31
|
Fujiya K, Kawamura T, Omae K, Makuuchi R,
Irino T, Tokunaga M, Tanizawa Y, Bando E and Terashima M: Impact of
malnutrition after gastrectomy for gastric cancer on long-term
survival. Ann Surg Oncol. 25:974–983. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sun Y, Zhang J, Guo F, Zhao W, Zhan Y, Liu
C, Fan Y and Wang J: Identification of apolipoprotein C-I peptides
as a potential biomarker and its biological roles in breast cancer.
Med Sci Monit. 22:1152–1160. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang D, Yuan W, Li H, Li S, Chen Z and
Yang H: Identification of key pathways and biomarkers in
sorafenib-resistant hepatocellular carcinoma using bioinformatics
analysis. Exp Ther Med. 16:1850–1858. 2018.PubMed/NCBI
|
|
34
|
Park J, Lee E, Park KJ, Park HD, Kim JW,
Woo HI, Lee KH, Lee KT, Lee JK, Park JO, et al: Large-scale
clinical validation of biomarkers for pancreatic cancer using a
mass spectrometry-based proteomics approach. Oncotarget.
8:42761–42771. 2017.PubMed/NCBI
|
|
35
|
Ahn HS, Shin YS, Park PJ, Kang KN, Kim Y,
Lee HJ, Yang HK and Kim CW: Serum biomarker panels for the
diagnosis of gastric adenocarcinoma. Br J Cancer. 106:733–739.
2012. View Article : Google Scholar : PubMed/NCBI
|
